4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-024713
Director sold 7,500 shares at an average $184.53 ($1,383,969)
From the SEC's structured data for this filing
Trades in this filing
STUELPNAGEL JOHN R · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-01 | Sale : show line 1 in the form | −241 | $180.27 | $43,446 | 443,250 | D |
| 2021-04-01 | Sale : show line 2 in the form | −200 | $181.83 | $36,365 | 443,050 | D |
| 2021-04-01 | Sale : show line 3 in the form | −700 | $183.19 | $128,233 | 442,350 | D |
| 2021-04-01 | Sale : show line 4 in the form | −2,272 | $184.22 | $418,539 | 440,078 | D |
| 2021-04-01 | Sale : show line 5 in the form | −3,487 | $185.21 | $645,844 | 436,591 | D |
| 2021-04-01 | Sale : show line 6 in the form | −600 | $185.90 | $111,542 | 435,991 | D |
| Open-market sales · 7,500 sh · avg $184.53 · $1,383,969 | ||||||
Loading xslF345X03/doc4.xml…